Genistein Improves Neuropathology and Corrects Behaviour in a Mouse Model of Neurodegenerative Metabolic Disease-Reference-Cited by-同舟云学术

Genistein Improves Neuropathology and Corrects Behaviour in a Mouse Model of Neurodegenerative Metabolic Disease

Published:2010-12-01 Issue:12 Volume:5 Page:e14192
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Malinowska Marcelina,Wilkinson Fiona L.,Langford-Smith Kia J.,Langford-Smith Alex,Brown Jillian R.,Crawford Brett E.,Vanier Marie T.,Grynkiewicz Grzegorz,Wynn Rob F.,Wraith J. Ed,Wegrzyn Grzegorz,Bigger Brian W.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. The frequency of lysosomal storage diseases in The Netherlands.;BJ Poorthuis;Hum Genet,1999

2. Lysosomal disorders.;JE Wraith;Semin Neonatol,2002

3. Limitations of enzyme replacement therapy: current and future.;JE Wraith;J Inherit Metab Dis,2006

4. Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy.;RF Wynn;J Pediatr,2009

5. Substrate reduction therapy.;FM Platt;Acta,2008

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic effects of resveratrol and enzyme replacement therapy in the Mucopolysaccharidosis type I;Biochemical Pharmacology;2024-11

2. Generation of a novel immunodeficient mouse model of Mucopolysaccharidosis type IIIA to test human stem cell-based therapies;Molecular Genetics and Metabolism;2024-09

3. Current Concepts in the Management of Sanfilippo Syndrome (MPS III): A Narrative Review;Cureus;2024-04-11

4. Efficacy of a Combination Therapy with Laronidase and Genistein in Treating Mucopolysaccharidosis Type I in a Mouse Model;International Journal of Molecular Sciences;2024-02-17

5. Low-molecular weight sulfated marine polysaccharides: Promising molecules to prevent neurodegeneration in mucopolysaccharidosis IIIA?;Carbohydrate Polymers;2023-11